Brief Article Open Access
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Hepatol. Sep 27, 2011; 3(9): 250-255
Published online Sep 27, 2011. doi: 10.4254/wjh.v3.i9.250
Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression
Annayya R Aroor, Shivendra D Shukla
Annayya R Aroor, Shivendra D Shukla, Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO 65212, United States
Author contributions: Aroor AR and Shukla SD designed the study, interpreted the data and wrote the manuscript; Shukla SD supervised the work and critically monitored its development.
Supported by (in part) NIH grant AA11962
Correspondence to: Shivendra D Shukla, PhD, Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO 65212, United States. shuklasd@missouri.edu
Telephone: +1-573-8822740 Fax: +1-573-8844558
Received: January 3, 2011
Revised: July 6, 2011
Accepted: August 10, 2011
Published online: September 27, 2011

Abstract

AIM: To investigated the status of low-density lipoprotein (LDL)-receptor and angiotensionogen gene expression in rats treated chronically with ethanol followed by binge administration, a model that mimics the human scenario.

METHODS: Rats were chronically treated with ethanol in liquid diet for 4 wk followed by a single binge mode of ethanol administration (5 mg/kg body weight). Samples were processed 4 h after binge ethanol administration (chronic ethanol binge). Control rats were fed isocaloric diet. In the control for binge, ethanol was replaced by water. Expression of mRNA for angiotensinogen, c-fos and LDL-receptor, and nuclear accumulation of phospho-extracellular regulated kinases (ERK)1/2 and ERK1/2 protein were examined.

RESULTS: Binge ethanol administration in chronically treated rats caused increase in steatosis and necrosis. Chronic ethanol alone had negligible effect on mRNA levels of LDL-receptor, or on the levels of nuclear ERK1/2 and phospho-ERK1/2. But, chronic ethanol followed by binge caused a decrease in LDL-receptor mRNA, and also decreased the levels of ERK1/2 and phospho-ERK1/2 in the nuclear compartment. On the other hand, chronic ethanol-binge increased mRNA expression of angiotensinogen and c-fos.

CONCLUSION: Binge ethanol after chronic exposure, causes transcriptional dysregulation of LDL-receptor and angiotensinogen genes, both cardiovascular risk factors.

Key Words: Alcoholic liver injury, Angiotensinogen, Ethanol binge, Extracellular regulated kinases1/2, Low-density lipoproteun-receptor, Plasminogen activator inhibitor-1



INTRODUCTION

A number of epidemiological studies have indicated that moderate alcohol use protects the individual from coronary heart disease[1,2]. In contrast to this cardioprotection, overconsumption or heavy drinking of alcohol is closely correlated with cardiovascular diseases such as hypertension, hemorrhagic and thrombotic stroke, cardiac arrhythmias, cardiomyopathy and acute coronary syndrome[3-6]. A common factor in the background for progression of liver damage and vascular injury in humans is heavy ethanol binge superimposed on chronic ethanol intake[7-9]. Notably, binge drinking is on the rise worldwide[10-12]. Two contributing factors related to cardiovascular risk in humans consuming heavy amounts of alcohol are increase in plasma low-density lipoprotein (LDL)-cholesterol[13], and increase in plasma plasminogen activator inhibitor (PAI)-1 levels[3,14]. In this regard, decreased expression of hepatic LDL-receptor[15], and increased expression of hepatic PAI-1[16], have been reported in animal models of alcoholic liver injury. We have recently reported a clinically relevant animal model of chronic ethanol binge that manifests exaggerated liver injury, activation of extracellular regulated kinases (ERK)1/2 and increased expression of PAI-1[17]. Activation of ERK1/2 is one of the signaling cascades that results in increased expression of LDL-receptor in hepatocytes[15], but the relationship of ERK1/2 activation to LDL-receptor expression after chronic ethanol binge has not been examined. Although, increased tumor necrosis factor (TNF)-α is one of the factors that can contribute to increased expression of hepatic PAI-1, TNF-α was not increased in our model, suggesting that other factors contribute to PAI-1 increase. In this regard, angiotensin II has been shown to induce expression of PAI-1 in vitro and in vivo[18,19]. To gain molecular insight into the effects of ethanol binge in liver, we determined the effects of binge ethanol in rats treated chronically (4 wk) with ethanol, on the expression of angiotensinogen and LDL-receptor genes and the status of ERK1/2 activation.

MATERIALS AND METHODS
Materials

Male Sprague-Dawley rats, each weighing between 250-300 mg were purchased from Harlan Laboratories (Indianapolis, IN) for chronic ethanol treatment. The antibodies for phospho-ERK1/2, ERK1/2 protein were purchased from Cell Signaling (Beverly, MA). The other reagents including protease inhibitors cocktail (Sigma p8340) and anti β-actin antibody were obtained from the Sigma-Aldrich (St. Louis, MO).

Animal feeding for chronic ethanol-binge model of alcoholic liver injury

Male Sprague-Dawley rats, each initially weighing 300 g,

were housed under a 12-h/12-h light/dark cycle and were permitted ad libitum consumption of standard laboratory rat chow. After a 1-wk equilibration period, the animals were fed Lieber-DeCarli liquid diet (Dyets, Inc., Bethlehem, PA)[20]. Ethanol was progressively introduced into the liquid diet starting at 1.25% (w/v) for day 1, increased to 1.67% (w/v) for day 2 and to 2.5% (w/v) for days 3 and 4, and, finally, maintained at 5% (w/v) for 4 wk. Weight-matched littermates were pair-fed on the same liquid diet, except the ethanol was replaced by dextrin/maltose (control) to maintain the isocaloric intake in the two groups. Each day, the previous day’s intake was measured, and the pair-fed rat was fed same calorie of dextrin/maltose. After 4 wk, rats were divided into four groups: control, chronic ethanol, control water, chronic ethanol binge. The chronic ethanol binge group had single binge intragastric administration of ethanol (5 mg/kg, body weight) for 4 h. In the control group for chronic ethanol binge, ethanol was replaced by water (control water). The animal care and protocol for their use were approved by the University of Missouri Animal Care and Use Committee.

Preparation of whole liver extracts, nuclear extracts and immunoblotting

Frozen liver was homogenized with hypotonic buffer containing 10 mmol/L HEPES, pH 7.4, 10 mmol/L β-glycerophosphate, 0.5 mmol/L EDTA, 0.5 mmol/L EGTA, 10 mmol/L sodium fluoride, 2.5 mmol/L sodium pyrophosphate 1 mmol/L Na-orthovanadate, 1.5 mmol/L MgCl2, 1 mmol/L dithiothreitol (DTT), Sigma p8340 protease inhibitor cocktail and 10% glycerol. The proteins in the homogenate were extracted and denatured by adding SDS to 1%. After boiling for 5 min, the homogenate was sonicated for 5 s and centrifuged at 12 000 g for 10 min. The supernatant was used for protein assay and western blotting. Protein concentration was measured using the Bio-Rad DC protein assay kit. The nuclear extracts were obtained following our previously published protocols[21,22]. The total liver extracts and nuclear fractions (60 to 80 μg protein) were combined with equal volume of 2 × Laemelli buffer and fractionated on 10% polyacrylamide gels and immunoblotting was performed as described earlier[22]. Equal loading of protein was confirmed by determining β-actin levels for whole cell extracts and histone H3 protein levels for nuclear extracts. Levels of β-actin or histone H3 did not change after chronic ethanol or binge treatments.

Histopathology and determination of alanine amino transfease

For light microscopy, formalin fixed specimens were sectioned and stained with hematoxylin and eosin. Serum alanine amino transfease (ALT) was determined in an autoanalyzer by kinetic assay.

Quantitative real-time polymerase chain reaction

Total RNA was extracted from the livers using the TRIzol reagent (Invitrogen) followed by DNase I treatment and clean up in Qiagen RNeasy midi kit (Qiagen). First strand cDNA was synthesized from one microgram of total RNA using the cDNA synthesis kit (Applied Biosystems). Reverse transcriptase-polymerase chain reaction (RT-PCR) reaction was performed using SYBR green supemix from Biorad using primers as shown in Table 1. Thermal cycling conditions were 95°C for 3 min as initial denaturation and enzyme-activating step followed by 40 cycles of 95°C for 15 s denaturation, and 57°C for 1 min annealing and extension. After amplification, a melting curve analysis was performed by increasing the temperature by 0.5°C increments from 55°C to 95°C and measuring fluorescence at each temperature for a period of 10 s. All cDNA samples were analyzed in triplicate and each run contained a relative standard curve. The expression of each gene was normalized to GAPDH and calculated to relative pair fed control using comparative cycle threshold method[23].

Table 1 Primers used for real time polymerase chain reaction.
GAPDH
Forward: 5'-AGACAGCCGCATCTTCTTGT-3'
Reverse: 5'-CTTGCCGTGGGTTAGAGTCAT-3'
LDL-receptor
Forward: 5'-TTCTTCAGGTTGGGGATCAG-3'
Reverse: 5'-CAGCTCTGTGTGAACCTGGA-3'
Angiotensinogen
Forward: 5'-GAGGCAAGAGGTGTAGCCAG-3'
Reverse: 5'-GCAGTCTCCCTCCTTCACAG-3'
c-fos
Forward: 5'-GCGGACTACGAGGCGTCAT-3'
Reverse: 5'-GGAGGAGACCAGAGT-3'
Statistical analysis

All results are expressed as mean ± SD and were obtained by combining data from individual experiments. Statistical analyses were made using the Student t test (two-tailed, paired, and unpaired). Differences with a P value of < 0.05 were considered significant.

RESULTS
Augmentation of ethanol binge induced injury after chronic ethanol intake

Administration of ethanol for 4 wk is known to result in mild steatosis and moderate increase in ALT. However, administration of a single ethanol binge caused a dramatic increase in steatosis (Figure 1). Ethanol binge also caused significant increase in ALT (2.2 fold increase, P < 0.05) compared to a moderate increase in chronic ethanol treated rats (1.4 fold, P > 0.05). Thus, chronic ethanol exposure increased the susceptibility of liver to binge-induced injury.

Figure 1
Figure 1 Histology of chronic and chronic ethanol-single binge liver samples. Rats were fed ethanol in liquid diet chronically for 4 wk and then given a single ethanol binge dose (5 mg/kg, 4 h). Sections of liver samples were stained with hematoxylin and eosin. Control -water represents pair-fed animals given water for binge control.
Decreased expression of LDL-receptor and decreased accumulation of ERK1/2 in the nucleus after chronic ethanol binge

The effect of chronic ethanol and ethanol binge on changes in LDL-receptor gene expression is shown in Figure 2. Although mRNA levels of LDL- receptor were not much affected by chronic ethanol, its levels significantly decreased after binge ethanol treatment. Activation of ERK1/2 is one of the important mechanisms for the expression of LDL receptor in hepatocytes[15,24]. A recent study showed expression of LDL receptor and activation of ERK1/2, were both decreased in chronic ethanol treated rats[15]. This finding is different from the chronic ethanol and chronic ethanol binge group in our earlier study[17]. In the current study, we found increased activation of ERK1/2 after chronic ethanol binge. We next determined the nuclear levels of phosphorylated ERK1/2, and ERK1/2 protein in liver from control and ethanol treated rats. In chronic ethanol treated rats, the nuclear levels of phospho-ERK1/2 were not significantly different from control rats whereas they were significantly lower in chronic ethanol binge group (Figure 3). The decrease in the levels of phospho-ERK1/2 was accompanied by decreased levels of ERK1/2 protein in nuclear extracts after chronic ethanol binge. These results suggest impaired translocation of activated ERK1/2 to the nuclear compartment after chronic ethanol-binge.

Figure 2
Figure 2 Low-density lipoprotein-receptor mRNA expression in chronic and chronic-binge treated rats. After 4 wk of chronic ethanol feeding, binge was administered as in Figure 1. Total RNA was isolated from liver and reverse transcribed to cDNA. Aliquots of the cDNA preparations were amplified by real time QT-PCR. The fold increase in gene expression was determined after normalizing the differences in level of GAPDH mRNA. Values are mean ± SD (n = 4). aP < 0.05 vs control; cP < 0.05 vs chronic ethanol group.
Figure 3
Figure 3 Levels of phosphorylated ERK1/2 (A/C) and ERK1/2 (B/D) protein in nuclear extracts in chronic and chronic-binge treated rats. The chronic ethanol feeding (4 wk) and binge (single) treatment was as in Figure 1. The nuclear extracts from liver were subjected to western blotting with respective antibodies, followed by densitometry of bands (see methods). Values are mean ± SD (n = 4). aP < 0.05 vs control; cP < 0.05 vs chronic ethanol group. C: Control (pair fed); E: Chronic ethanol; E-B: Chronic-ethanol binge.
Increased expression of angiotensionogen and c-fos expression

We have previously shown that PAI-1 gene expression is increased after chronic ethanol binge[17]. TNF-α is one of the cytokine that has been implicated in the up regulation of PAI-1 expression[16]. However, we did not find increased expression of TNF-α after ethanol binge[17]. PAI-1 gene expression has been shown to be induced by angiotensin II[18,19], and angiotensin II levels in plasma are increased by ethanol binge after chronic ethanol consumption in humans[25], but no such studies have been done in animal models of alcoholic liver injury. Therefore, we determined the level of angiotensinogen gene expression in liver samples. Angiotensinogen gene expression was not altered after chronic ethanol treatment, whereas its expression was significantly increased after chronic ethanol-binge treatment (Figure 4). In this regard, c-fos, is one of the transcription factors regulating PAI-1 expression, and angiotensin II has been shown to stimulate c-fos expression in hepatocytes in vitro[26]. Although the expression of c-fos was not altered by chronic ethanol treatment, its expression was significantly increased by binge (Figure 4) and the pattern of changes in c-fos expression was similar to that of angiotensionogen.

Figure 4
Figure 4 Angiotensionogen (A) and c-fos mRNA (B) expression in chronic and chronic-binge treated rats. After 4 wk of chronic ethanol feeding, single binge was administered as in Figure 1. Total RNA was isolated from liver and reverse transcribed to cDNA. Aliquots of the cDNA preparations were amplified by real time QT-PCR. The fold increase in gene expression was determined after normalizing the differences in level of GAPDH mRNA. Values are mean ± SD (n = 4). aP < 0.05 vs control; cP < 0.05 vs chronic ethanol group.
DISCUSSION

This is the first report demonstrating changes in two important factors, known to contribute to cardiovascular risk associated with heavy ethanol consumption in humans, in a clinically relevant chronic ethanol-binge rat model. Chronic ethanol-binge was characterized by decreased expression of LDL-receptor and increased expression of angiotensionogen gene. Decreased expression of hepatic LDL-receptor in humans is associated with increased plasma LDL-cholesterol levels and heavy alcohol consumption is associated with increased plasma LDL-cholesterol levels[13]. ERK1/2 activation is reported to be involved in the induction of LDL-receptor expression in hepatocytes in vitro[15,24]. We have recently reported activation of ERK1/2 by chronic ethanol binge[17], but observed a decrease in LDL-receptor expression (Figure 2). In order to address these apparently contradictory findings, we have examined the nuclear levels of phosphorylated ERK1/2 in the chronic ethanol binge group and have found an impaired accumulation of nuclear phospho-ERK1/2 and ERK1/2 protein. Decreased expression of LDL receptor by inhibition of mitogen-activated protein kinase (MAPK) signaling in HepG2 cells under basal conditions[15], or after agonist stimulation[24], coupled with decreased nuclear ERK1/2 as reported here, implies dysregulation of compartmentalization of MAPK signaling by chronic ethanol binge. Although, the mechanism underlying impaired accumulation is not known at present, exaggerated oxidative stress may be one of the determining factors for impaired translocation of ERK1/2 to the nucleus. In this regard, hydrogen peroxide has been shown to cause impaired accumulation of ERK1/2 in cultured rat hepatocytes[27], and chronic ethanol administration followed by intraperiotoneal administration of ethanol has been shown to exaggerate oxidative stress in the liver[28].

Increased plasma PAI-levels were more correlated to stetaosis in humans than adipose tissue fat accumulation, suggesting liver is one of the major sources for circulating PAI-1 levels[29]. Increased levels of circulating PAI-1 have been reported after heavy ethanol binge in people with prolonged ethanol consumption[3,5]. Angiotensin II is one of the agonists known to stimulate the expression of angiotensinogen gene in the liver, and plasma levels of angiotensin II are correlated to hepatic angiotensinogen expression[19]. Plasma angiotensin II levels were reportedly increased to significantly higher levels compared to acute binge type of ethanol administration in humans[27]. In the present study, chronic ethanol binge was accompanied by a significant increase in angiotensiogen gene expression thereby suggesting a possible relationship between PAI-1 gene expression and angiotensiongen gene expression. These data pave the way for future studies to correlate this binge effect to measures of vascular injury in vivo. It should be noted that the major source of angiotensinogen, PAI-1, and LDL-receptor is hepatocytes. Therefore, studies on whole liver homogenates are fairly representative of hepatocyte injury; since hepatocytes account for more than 80% of liver cells. Although, involvement of non-parenchymal cells cannot be excluded at present, the results suggest a role of liver as a whole in the dysregulation of cardiovascular risk factors, by chronic ethanol binge. Although mechanisms of angiotensinogen expression are not clear, inhibition of ERK1/2 activation was associated with increased expression of the angiotensinogen gene in renal tubular cells in an oxidative stress-dependent manner[30]. This raises the possibility that decreased nuclear translocation of ERK1/2, observed in the present study, may modulate angiotensinogen gene expression. Expression of PAI-1 has been linked to ERK1/2 activation in vitro and in vivo[16,31], but in this study, nuclear accumulation of ERK1/2 was decreased after chronic ethanol binge (Figure 3). However, regulation of PAI-1 expression also occurs by ERK1/2-independent mechanisms[32]. In this regard, expression of c-fos, one of the transcription factors regulating PAI-1 expression, can also occur in an ERK-independent but redox-sensitive manner[33]. Angiotensin II causes activation of NAPDH oxidase and oxidative stress[34]. Increased expression of c-fos after ethanol binge and the similar pattern of changes in c-fos expression and angiotensionogen supports a relationship between the expression of these two genes.

In summary, the present study offers the first evidence that ethanol binge, after chronic ethanol intake, is associated with decreased LDL-receptor and increased angiotensinogen gene expression. Decreased expression of LDL-receptor is accompanied by decreased accumulation of phosphorylated ERK1/2 in the nuclear compartment, whereas increase in angiotensionogen gene expression is accompanied by increased expression of transcription factor c-fos. These ethanol binge-induced changes have significant implications for cardiovascular risk.

ACKNOWLEDGMENTS

We are grateful to Mr. Daniel Jackson for expert technical assistance.

COMMENTS
Background

Binge drinking of ethanol is on the rise worldwide. Epidemiological studies indicate that this has caused alarming increase in liver and cardiovascular damage. The molecular mechanisms of this damage are not well defined. This article focuses onto this aspect.

Research frontiers

The angiotensin and low-density lipoprotein (LDL) receptor are important players in the cardiovascular complications. Both are generated in the liver and therefore highlight the importance of the contribution of liver to vascular events. Binge ethanol is shown here to influence both components.

Innovations and breakthroughs

This is the first report in a clinically relevant animal model demonstrating that binge ethanol in chronically consuming rats caused dramatic alterations in genes for angiotensinogen and LDL receptor. This offers a new mechanistic understanding of the binge ethanol effect relevant to cardiovascular complications observed in alcoholics.

Applications

The observations have clinical ramifications for future development of tools to control cardiovascular problems in chronic binge drinkers.

Terminology

Binge ethanol is repeat episodic drinking of alcohol.

Peer review

This is a very elegant study on the mechanism of liver damage from binge alcohol consumption.

Footnotes

Peer reviewer: Volker Fendrich, MD, Department of Surgery, Philipps-University, Marburg 35039, Germany

S- Editor Zhang SJ L- Editor Hughes D E- Editor Zheng XM

References
1.  O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol. 2007;50:1009-1014.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 284]  [Cited by in F6Publishing: 198]  [Article Influence: 20.3]  [Reference Citation Analysis (0)]
2.  Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease. Circulation. 2010;121:1951-1959.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 66]  [Cited by in F6Publishing: 20]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
3.  Djoussé L, Pankow JS, Arnett DK, Zhang Y, Hong Y, Province MA, Ellison RC. Alcohol consumption and plasminogen activator inhibitor type 1: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J. 2000;139:704-709.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Klatsky AL. Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension: does it matter? Yes. J Cardiovasc Risk. 2003;10:21-24.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Foerster M, Marques-Vidal P, Gmel G, Daeppen JB, Cornuz J, Hayoz D, Pécoud A, Mooser V, Waeber G, Vollenweider P. Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol. 2009;103:361-368.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 77]  [Cited by in F6Publishing: 59]  [Article Influence: 5.9]  [Reference Citation Analysis (0)]
6.  Numminen H, Syrjälä M, Benthin G, Kaste M, Hillbom M. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. Stroke. 2000;31:1269-1273.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Ceccanti M, Attili A, Balducci G, Attilia F, Giacomelli S, Rotondo C, Sasso GF, Xirouchakis E, Attilia ML. Acute alcoholic hepatitis. J Clin Gastroenterol. 2006;40:833-841.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 50]  [Cited by in F6Publishing: 33]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
8.  Zakhari S, Li TK. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology. 2007;46:2032-2039.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 199]  [Cited by in F6Publishing: 169]  [Article Influence: 15.3]  [Reference Citation Analysis (0)]
9.  Mathurin P, Beuzin F, Louvet A, Carrié-Ganne N, Balian A, Trinchet JC, Dalsoglio D, Prevot S, Naveau S. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther. 2007;25:1047-1054.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 93]  [Cited by in F6Publishing: 79]  [Article Influence: 6.6]  [Reference Citation Analysis (0)]
10.  Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223-2233.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2059]  [Cited by in F6Publishing: 784]  [Article Influence: 171.6]  [Reference Citation Analysis (0)]
11.  Mathurin P, Deltenre P. Effect of binge drinking on the liver: an alarming public health issue? Gut. 2009;58:613-617.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 92]  [Cited by in F6Publishing: 70]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
12.  Bobak M, Room R, Pikhart H, Kubinova R, Malyutina S, Pajak A, Kurilovitch S, Topor R, Nikitin Y, Marmot M. Contribution of drinking patterns to differences in rates of alcohol related problems between three urban populations. J Epidemiol Community Health. 2004;58:238-242.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Kiechl S, Willeit J, Rungger G, Egger G, Oberhollenzer F, Bonora E. Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke. 1998;29:900-907.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  van de Wiel A, de Lange DW. Cardiovascular risk is more related to drinking pattern than to the type of alcoholic drinks. Neth J Med. 2008;66:467-473.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Wang Z, Yao T, Song Z. Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver. Alcohol Clin Exp Res. 2010;34:471-478.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 45]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
16.  Beier JI, Luyendyk JP, Guo L, von Montfort C, Staunton DE, Arteel GE. Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology. 2009;49:1545-1553.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 49]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
17.  Aroor AR, Jackson DE, Shukla SD. Elevated Activation of ERK1 and ERK2 Accompany Enhanced Liver Injury Following Alcohol Binge in Chronically Ethanol-Fed Rats. Alcohol Clin Exp Res. 2011;Epub ahead of print.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Vaziri ND, Xu ZG, Shahkarami A, Huang KT, Rodríguez-Iturbe B, Natarajan R. Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Kidney Int. 2005;68:2787-2793.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 33]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
19.  Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int. 2000;58:251-259.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 123]  [Cited by in F6Publishing: 105]  [Article Influence: 5.9]  [Reference Citation Analysis (0)]
20.  Lieber CS, DeCarli LM. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin Exp Res. 1982;6:523-531.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Park PH, Lim RW, Shukla SD. Involvement of histone acetyltransferase (HAT) in ethanol-induced acetylation of histone H3 in hepatocytes: potential mechanism for gene expression. Am J Physiol Gastrointest Liver Physiol. 2005;289:G1124-G1136.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 75]  [Cited by in F6Publishing: 68]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
22.  Aroor AR, James TT, Jackson DE, Shukla SD. Differential changes in MAP kinases, histone modifications, and liver injury in rats acutely treated with ethanol. Alcohol Clin Exp Res. 2010;34:1543-1551.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 34]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
23.  Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarençon D, Agay D, Chancerelle Y, Multon E. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 2004;5:3.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 182]  [Cited by in F6Publishing: 172]  [Article Influence: 10.7]  [Reference Citation Analysis (0)]
24.  Kong WJ, Liu J, Jiang JD. Human low-density lipoprotein receptor gene and its regulation. J Mol Med (Berl). 2006;84:29-36.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 31]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
25.  Rosseland CM, Wierød L, Oksvold MP, Werner H, Ostvold AC, Thoresen GH, Paulsen RE, Huitfeldt HS, Skarpen E. Cytoplasmic retention of peroxide-activated ERK provides survival in primary cultures of rat hepatocytes. Hepatology. 2005;42:200-207.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 52]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
26.  Kanbagli O, Balkan J, Aykaç-Toker G, Uysal M. Hepatic mitochondrial prooxidant and antioxidant status in ethanol-induced liver injury in rats. Biol Pharm Bull. 2002;25:1482-1484.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Collins GB, Brosnihan KB, Zuti RA, Messina M, Gupta MK. Neuroendocrine, fluid balance, and thirst responses to alcohol in alcoholics. Alcohol Clin Exp Res. 1992;16:228-233.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  González-Espinosa C, García-Sáinz JA. Hormonal modulation of c-fos expression in isolated hepatocytes. Effects of angiotensin II and phorbol myristate acetate on transcription and mRNA degradation. Biochim Biophys Acta. 1996;1310:217-222.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol. 2003;23:1262-1268.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 124]  [Cited by in F6Publishing: 36]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
30.  Hsieh TJ, Fustier P, Wei CC, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS. Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol. 2004;183:535-550.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 32]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
31.  Nagamine Y. Transcriptional regulation of the plasminogen activator inhibitor type 1--with an emphasis on negative regulation. Thromb Haemost. 2008;100:1007-1013.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Paugh BS, Paugh SW, Bryan L, Kapitonov D, Wilczynska KM, Gopalan SM, Rokita H, Milstien S, Spiegel S, Kordula T. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 2008;22:455-465.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 57]  [Article Influence: 4.6]  [Reference Citation Analysis (0)]
33.  Kutz SM, Providence KM, Higgins PJ. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells. Cell Motil Cytoskeleton. 2001;48:163-174.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
34.  Wei Y, Clark SE, Morris EM, Thyfault JP, Uptergrove GM, Whaley-Connell AT, Ferrario CM, Sowers JR, Ibdah JA. Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. J Hepatol. 2008;49:417-428.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]